MannKind Corporation

MNKD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $349.0M $285.5M $199.0M $99.8M $75.4M $65.1M $63.0M $27.9M
Cost of Revenue $26.8M $17.4M $20.9M $16.0M $16.8M $15.1M $20.1M $19.4M
Gross Profit $322.2M $268.1M $178.1M $83.8M $58.6M $50.1M $43.0M $8.5M
Gross Margin 92.3% 93.9% 89.5% 84.0% 77.7% 76.8% 68.1% 30.4%
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $144.1M $94.3M $94.3M $91.5M $77.4M $59.0M $74.7M $79.7M
Operating Income $38.8M $72.6M $8.7M $-64.1M $-47.0M $-47.9M $-44.6M $-76.6M
Operating Margin 11.1% 25.4% 4.4% -64.3% -62.3% -73.5% -70.7% -274.9%
Interest Expense — — $15.2M $15.0M $15.2M $9.5M $6.3M $5.1M
Pretax Income $1.4M $30.5M $-10.4M $-87.4M $-80.9M $-57.5M $-51.9M $-86.7M
Income Tax Expense $-4.5M $2.9M $1.6M $0 $0 $-218.0K $0 $240.0K
Net Income $5.9M $27.6M $-11.9M $-87.4M $-80.9M $-57.2M $-51.9M $-87.0M
Net Margin 1.7% 9.7% -6.0% -87.6% -107.3% -87.9% -82.3% -312.2%
EPS (Basic) $0.02 $0.10 $-0.04 $-0.34 $-0.32 $-0.26 $-0.27 $-0.60
EPS (Diluted) $0.02 $0.10 $-0.04 $-0.34 $-0.32 $-0.26 $-0.27 $-0.60
Shares Outstanding (Basic) 305.6M 274.4M 267.0M 257.1M 249.2M 222.6M 211.8M 144.1M
Shares Outstanding (Diluted) 314.1M 283.8M 267.0M 257.1M 249.2M 222.6M 211.8M 144.1M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 2 Older →